Plain-English translation of NCT04290000 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is collecting blood samples from patients who are receiving CAR-T cell therapy—an advanced treatment where doctors take your own immune cells, reprogram them to fight cancer, and put them back into your body. By studying your blood samples over time, researchers hope to understand why this powerful treatment works brilliantly for some patients but not for others, so they can make it work better for everyone.
Even though medications like Yescarta and Kymriah have shown impressive results in early studies, about half of patients don't respond to the treatment as hoped. Researchers believe this may be because the CAR-T cells don't expand enough in the body, lose their strength, or don't last long enough. By examining blood samples from treated patients, scientists want to figure out exactly what goes wrong when treatment fails so they can improve the therapy.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate blood samples at the hospital where you're receiving your CAR-T cell treatment. The research team will collect these samples alongside your regular medical care and use them to study how your immune cells are responding to the treatment. Clinical information about your response to the medication will also be recorded to help connect what researchers find in your blood to your overall health outcomes.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
France